PURPOSE: To identify visually significant spectral-domain optical coherence tomography (SD-OCT) features of epiretinal membranes (ERM) in patients with uveitis. DESIGN: Retrospective cohort and cross-sectional study. METHODS: Eighty consecutive eyes with uveitis and SD-OCT-documented ERM were included. Clinical data were collected at the time of diagnosis of ERM and at the final visit. SD-OCT images at the last visit were evaluated to identify fovea and ERM configuration and structural changes. Changes of 10% and 20% in central subfield thickness between initial and last SD-OCT were calculated and correlated with visual acuity (VA). An ERM thickness map was created using validated SD-OCT grading software. RESULTS: VA improved significantly in eyes with more than 12 months of follow-up (P = .03). Although inflammation activity and medical treatment methods were no different in eyes with more or less than 12 months of follow-up, 16 eyes in the subset with longer follow-up underwent cataract extraction and intraocular lens implantation. Kaplan-Meier analysis demonstrated few vision losses during the follow-up period. Change in central subfield thickness did not correlate with VA. Foveal center involvement (P < .001), focal attachment of the ERM (P = .003), and foveal inner segment and outer segment junction disruption (P = .006) were associated independently with lower VA. ERM was thinner in eyes with 20/40 or better VA (4.6 ± 0.6 μm) compared with eyes with VA of less than 20/200 (P = .02). Longer duration of ERM was associated with thicker ERM (P < .05). CONCLUSIONS: In most eyes with uveitis and ERM, VA remains stable if ocular inflammation and comorbidities are addressed appropriately.
PURPOSE: To identify visually significant spectral-domain optical coherence tomography (SD-OCT) features of epiretinal membranes (ERM) in patients with uveitis. DESIGN: Retrospective cohort and cross-sectional study. METHODS: Eighty consecutive eyes with uveitis and SD-OCT-documented ERM were included. Clinical data were collected at the time of diagnosis of ERM and at the final visit. SD-OCT images at the last visit were evaluated to identify fovea and ERM configuration and structural changes. Changes of 10% and 20% in central subfield thickness between initial and last SD-OCT were calculated and correlated with visual acuity (VA). An ERM thickness map was created using validated SD-OCT grading software. RESULTS: VA improved significantly in eyes with more than 12 months of follow-up (P = .03). Although inflammation activity and medical treatment methods were no different in eyes with more or less than 12 months of follow-up, 16 eyes in the subset with longer follow-up underwent cataract extraction and intraocular lens implantation. Kaplan-Meier analysis demonstrated few vision losses during the follow-up period. Change in central subfield thickness did not correlate with VA. Foveal center involvement (P < .001), focal attachment of the ERM (P = .003), and foveal inner segment and outer segment junction disruption (P = .006) were associated independently with lower VA. ERM was thinner in eyes with 20/40 or better VA (4.6 ± 0.6 μm) compared with eyes with VA of less than 20/200 (P = .02). Longer duration of ERM was associated with thicker ERM (P < .05). CONCLUSIONS: In most eyes with uveitis and ERM, VA remains stable if ocular inflammation and comorbidities are addressed appropriately.
Authors: Srinivas R Sadda; Sandra Joeres; Ziqiang Wu; Paul Updike; Peggy Romano; Allyson T Collins; Alexander C Walsh Journal: Invest Ophthalmol Vis Sci Date: 2007-02 Impact factor: 4.799
Authors: John E Legarreta; Giovanni Gregori; Robert W Knighton; Omar S Punjabi; Geeta A Lalwani; Carmen A Puliafito Journal: Am J Ophthalmol Date: 2008-03-14 Impact factor: 5.258
Authors: Diana V Do; Minhee Cho; Quan Dong Nguyen; Syed Mahmood Shah; James T Handa; Peter A Campochiaro; Ingrid Zimmer-Galler; Jennifer U Sung; Julia A Haller Journal: Trans Am Ophthalmol Soc Date: 2006
Authors: Sandra Joeres; Jerry W Tsong; Paul G Updike; Allyson T Collins; Laurie Dustin; Alexander C Walsh; Peggy W Romano; SriniVas R Sadda Journal: Invest Ophthalmol Vis Sci Date: 2007-09 Impact factor: 4.799
Authors: Benjamin P Nicholson; Mei Zhou; Mahdi Rostamizadeh; Preema Mehta; Elvira Agrón; Wai Wong; Henry Wiley; Robert Nussenblatt; H Nida Sen Journal: Ophthalmology Date: 2014-07-23 Impact factor: 12.079
Authors: Igor Kozak; Vijay Vaidya; Mark L Van Natta; Jeong W Pak; K Patrick May; Jennifer E Thorne Journal: Invest Ophthalmol Vis Sci Date: 2014-06-12 Impact factor: 4.799
Authors: Brian Lehpamer; Erin Moshier; Patricia Pahk; Naomi Goldberg; Jessica Ackert; James Godbold; Douglas A Jabs Journal: Am J Ophthalmol Date: 2014-01-30 Impact factor: 5.258
Authors: Alice Y Kim; Damien C Rodger; Anoush Shahidzadeh; Zhongdi Chu; Nicole Koulisis; Bruce Burkemper; Xuejuan Jiang; Kathryn L Pepple; Ruikang K Wang; Carmen A Puliafito; Narsing A Rao; Amir H Kashani Journal: Am J Ophthalmol Date: 2016-09-02 Impact factor: 5.258
Authors: Ludovico Iannetti; Paolo Tortorella; Enzo D'Ambrosio; Rossela Spena; Roberta Zito; Magda Gharbiya Journal: Biomed Res Int Date: 2013-11-05 Impact factor: 3.411